The CompanyAAVantgarde is a clinical-stage international biotechnology company headquartered in Italy. We have developed two cutting-edge AAV vector platforms to overcome DNA cargo limitations targeting Usher syndrome type 1B and Stargardt disease. Founded by the renowned Professor Al
More...